LexaGene has a huge upside, says iA CapitalStellick sees upside ahead, though, and along with the recent MiQLab sales she pointed to a few more reasons investors should be excited about the stock and company. In particular, Stellick noted that LexaGene is now a member of the American Animal Hospital Association, the only accreditation organization for veterinary hospitals, which will provide networking opportunities for the company, the announcement last month of a new sample preparation cartridge which is essentially an upgrade to the MiQLab consumable sample preparation cartridge and one which will broaden the scope of applicability for the MiQLab, and also LexaGenes taking on of a new strategic investor: the company closed in February on the second of two tranches of a private placement to Meridian LGH Holdings, issuing 18.5 million warrants at an exercise price of $0.45 per share.